A recent analysis of drug trials, published in the Annals of Internal Medicine, indicates that studies are much more likely to show positive results (indicating that the drug worked) when they are funded by the pharmaceutical industry.
There were 546 drug trials reviewed as part of this analysis, generating the following data:
- 85% of industry-funded trials reported positive outcomes
- 50% of government-funded trials reported positive outcomes
- 72% of trials funded by nonprofits or non-federal organizations reported positive results
- In studies funded by nonprofits and non-federal organizations, 85% of studies receiving contributions from the pharmaceutical industry produced positive outcomes compared to 61% of studies that did not receive any financial contributions from the pharmaceutical industry
The study also indicated a significant disparity among the length of time it takes for the results of studies to be published:
- 32% of industry-funded studies were published within two years of the study’s completion
- 54% of government-funded trials were published within two years of the study’s completion
- 56% of nonprofit and non-federal trials were completed within two years of the study’s completion
Publishing the results of these studies in a timely manner prevents manipulating data or selectively publishing some results while withholding others.
It is clear that consumers must evaluate the source of a study’s financial backing when determining its validity. Pharmaceutical companies have a great deal at stake with drugs that make it to the clinical testing phase. Often, they have already invested millions if not billions of dollars in the development of these drugs, and they stand to make billions once they are approved. It is unfortunate that such a strong bias exists in the outcome of these clinical trials. It is clear that in some cases, the pharmaceutical industry may be placing profits above the safety of consumers.
If you have been injured as a result of taking a dangerous or defective drug, you may be entitled to receive compensation for your damages. It is important to consult with an experienced pharmaceutical injury lawyer who can advise you on the best way to proceed with your claim.
If you have a defective drug claim, please contact the nationwide pharmaceutical injury lawyers at Schlichter, Bogard & Denton today to schedule your free initial consultation.
